Introduction
============

AMPA-type glutamate receptors (AMPARs) are ligand-gated ion channels that mediate fast excitatory transmission throughout the CNS. They exist as homomeric or heteromeric assemblies of the pore-forming subunits GluA1, -2, -3, and -4, encoded by the genes, *GRIA1-4* ([@B96]). Receptor heterogeneity is increased by RNA processing events, alternative splicing and adenosine-to-inosine (A-to-I) RNA editing ([@B62]), and by the association of the various AMPARs with different members of large pool of auxiliary proteins ([@B77]; [@B97]; [@B76]; [@B78]). Importantly, differences in the core subunit and auxiliary protein content, as well as a variety of post-translational modifications, can considerably alter the trafficking and functional properties of the receptors ([@B96]; [@B27]; [@B22]).

Although patterns of subunit expression and different inter-subunit affinities dictate that the majority of AMPARs in the brain are heteromeric assemblies containing GluA2, receptors lacking GluA2 also exist ([@B99]; [@B73]; [@B46]; [@B70]). The GluA2 subunit plays a particularly significant role in dictating AMPAR ion selectivity and voltage dependence. RNA editing of GluA2 replaces a genomically encoded glutamine with a positively charged arginine at the Q/R site in the M2 re-entrant transmembrane loop that forms the lining of the channel pore. The positively charged arginine prevents the passage of Ca^2+^ ions ([@B26]; [@B85]; [@B12]), thus AMPARs containing edited GluA2 are termed Ca^2+^ impermeable (CI). Conversely, the absence of GluA2, or lack of editing, gives rise to a subset of AMPARs that are Ca^2+^ permeable (CP) ([@B28]; [@B10]). CP-AMPARs exhibit voltage-dependent channel block by endogenous intracellular polyamines such as spermine, which greatly limits current flow at depolarized voltages ([@B9]; [@B15]; [@B29]; [@B32]) and thus intracellular spermine-dependent rectification is an oft-used proxy for Ca^2+^ permeability (but see [@B8]). GluA2-lacking (CP-) AMPARs typically desensitize faster than GluA2-containing (CI-) AMPARs ([@B18]; [@B4]; [@B83]) and have a higher single-channel conductance ([@B87]; [@B16]).

While less abundant than their CI counterparts, CP-AMPARs are nevertheless widespread and have often been observed at excitatory connections onto inhibitory neurons (INs), where they play several important roles as discussed below ([@B24]; [@B47]; [@B34]; [@B57]). However, it remains unclear whether CP-AMPAR expression is restricted to specific IN subtypes ([@B102]; [@B3]; [@B91]) or is rather a reflection of developmental origin ([@B50]). Here we review recent studies indicating cell-type-specific expression of CP-AMPARs in a subset of INs and discuss the functional implications in health and disease.

Known Roles of CP-AMPARs
========================

Ca^2+^ is well known to play a key role in mediating synaptic plasticity ([@B81]; [@B82]; [@B48]). Consequently, CP-AMPARs are critical in regulating long-term changes in excitatory connections onto various IN types ([@B34]; [@B37]; [@B57]). Moreover, due to their voltage dependence being essentially opposite to that of NMDA receptors (NMDARs), CP-AMPARs may enable non-Hebbian plasticity at connections from PCs onto INs ([@B34]). For example, the induction of long-term potentiation (LTP) at excitatory inputs onto O-LM cells in the hippocampus requires presynaptic release of glutamate coincident with postsynaptic hyperpolarization, rather than the depolarization that is otherwise required for Hebbian plasticity. This non-Hebbian form of plasticity plays an important role in the hippocampal feedback circuit and may orchestrate the overall excitability of PCs ([@B34]). In contrast, a mechanism involving CP-AMPARs but leading to LTP of excitatory inputs onto INs in the absence of postsynaptic hyperpolarization has been observed in the basolateral amygdala ([@B47]), where excitatory synaptic transmission onto INs seems entirely meditated by CP-AMPARs. Here, tetanic stimulation leads to LTP in an NMDAR-independent yet Ca^2+^-dependent manner.

Specific IN types may also require CP-AMPARs to compartmentalize their response to excitatory inputs. In excitatory cells, dendritic spines serve as biochemical compartments, which promotes synapse specificity in long-term plasticity, which in turn ensures optimal information storage capacity ([@B21]; [@B84]; [@B82]; [@B48]). Although INs in general seem to have fewer spines than excitatory cells do, there appears to be a clear distinction among different classes of INs: spines are found at ∼7-fold higher density in somatostatin (Sst) than in parvalbumin (Pvalb)-expressing INs ([@B30]). Pvalb --- which is highly expressed in BCs ([@B25]) --- is a slow Ca^2+^-binding protein that contributes to the high endogenous Ca^2+^-buffering capacity of this cell type ([@B41]; [@B21]; [@B5]). This high Ca^2+^ buffering capacity helps to compartmentalize dendritic Ca^2+^ signals in BCs without interfering with the rapid and localized CP-AMPAR-mediated Ca^2+^ transients ([@B21]; [@B5]). To overcome the lack of dendritic spine-dependent Ca^2+^ compartmentalization, BCs might thus rely on the combined effects of CP-AMPARs fast kinetics and Pvalb expression. Consistent with the view that spines are particularly associated with a need for compartmentalization of relatively slow Ca^2+^ transients mediated by NMDARs, recent findings show that NMDARs are enriched in synapses onto spines as compared to dendrites in Pvalb-positive INs of mouse visual cortex ([@B72] Cell Reports). Perhaps this differential localization of NMDARs and AMPARs also ties it in with their engagement in different signaling pathways. Even so, the more rapid kinetics of CP-AMPARs may ensure that compartmentalization by spines is not necessary.

CP-AMPARs are Located at Specific Synapse Types
===============================================

MCs and BCs, two well-studied IN classes, are likely to take on distinctive roles in the neocortical microcircuit. While strongly facilitating excitatory inputs onto the distal dendrite-targeting MCs make them operate as high-pass filters, enabling delayed-onset feedback inhibition ([@B80]), the depressing excitatory inputs onto soma-targeting BCs make them act as low-pass filters ([@B7]), providing early onset feed-forward inhibition of PCs ([@B31]; [@B11]; **Figure [1](#F1){ref-type="fig"}**). We found that the specific expression of CP-AMPARs at PC to BC connections contributes significantly to the rapid feed-forward inhibition onto PCs ([@B36]), resulting in a shortened integrative time window for excitation ([@B63]; [@B51]).

![CP-AMPARs are synapse-type-specifically expressed in cortical layer 5. **(A)** As indicated by CP in green, CP-AMPARs are expressed at synapses from neocortical layer-5 pyramidal cells ("PC," black) onto basket cells ("BC," red) but not onto Martinotti cells ("MC," blue) as indicated by CI in red (see [@B36]). Because CP-AMPARs have faster kinetics, this differential expression helps ensure that BC-mediated somatic inhibition of PCs is fast. However, fast CP-AMPARs would counteract the delayed-onset, dendritic MC-mediated feedback inhibition of PCs ([@B80]; [@B11]), which may help explain this differential CP-AMPAR expression. Interestingly, this expression pattern is the precise opposite to that of presynaptic NMDA receptors ([@B11]). **(B)** In the hippocampal CA1 circuit, CP-AMPARs are found at excitatory connections onto both BCs and O-LM cells. Interestingly, [@B89] also identified CP-AMPARs at PC connections onto nitric oxide synthase-expressing hippocampal INs but not onto cholecystokinin-expressing INs. Excitatory synapses are indicated by open triangles, while open circles denote inhibitory synapses. Modified from ([@B7]) with appropriate permission.](fnsyn-10-00034-g001){#F1}

Using a combination of immunolabelling, paired recording, AMPA uncaging, and pharmacology, we demonstrated expression of CP-AMPARs at excitatory inputs onto BCs but not MCs ([@B36]). Immunolabelling showed that GluA2 was almost absent from the somata of Pvalb-expressing cells, contrasting with its strong presence in the somata of Sst-positive INs and even stronger labeling in PCs. We confirmed this observation using paired recordings of connections between PCs and both IN types: unlike those in MCs, AMPAR-mediated currents in BCs were inwardly rectifying (as demonstrated by their current-voltage relationships) and were sensitive to polyamines (**Figure [2](#F2){ref-type="fig"}**; [@B36]). The synapse-specific expression of CP-AMPARs was further supported by the faster decay kinetics of currents in BCs compared to MCs.

![Paired recordings reveal AMPAR rectification at PC-BC but not PC-MC synapses **(A)** 2-photon microscopy maximum intensity projection of a quadruple recording where a connection from morphologically identified cell 1 (PC) to cell 3 (BC) was measured. Scale bar: 50 μm. **(B)** AMPAR responses to PC 1 stimulation in BC 3 were recorded at various holding potentials (from --60 to + 60 mV). Inward rectification in the presence of intracellular spermine indicated the presence of CP-AMPARs. Scale bars: 10 ms, 100 pA. **(C)** In another paired recording, the AMPAR currents recorded from an MC in response to stimulation of the presynaptic PC did not show inward rectification, suggesting the absence of CP-AMPARs. Scale bars: 50 pA. **(D)** The cell-specific difference in rectification was robust, as shown by the pooled values of rectification index (RI) for PC-BC (red) and PC-MC (blue) paired recordings. Modified from ([@B36]) with appropriate permissions.](fnsyn-10-00034-g002){#F2}

The specific expression of CP-AMPARs in BCs, or at least in INs that express Pvalb or exhibit fast-spiking (two key properties of BCs), has been observed in several studies conducted in both neocortical and hippocampal circuits. In the rat, outside-out somatic patches from both BCs in dentate gyrus and fast-spiking INs in the neocortex showed inwardly rectifying currents with fast kinetics ([@B18]; [@B33]; [@B4]). When measured, a low abundance of GluA2 mRNA correlated with these markers of CP-AMPARs expression ([@B18]; [@B4]). [@B98] also observed inward rectification of excitatory inputs onto most fast-spiking INs in the rat prefrontal cortex, presumably reflecting the expression of CP-AMPARs (also see [@B90]). Most studies of different brain areas have thus identified CP-AMPARs in BCs or at least in INs showing key BC-like properties.

In the hippocampus however, there is also convincing evidence that developmental origin rather than IN type alone determines whether or not CP-AMPARs are expressed ([@B50]). Here, medial ganglionic eminence derived IN synapses are dominated by GluA2-lacking AMPARs, whereas caudal ganglionic eminence derived IN synapses had GluA2-containing AMPARs ([@B50]) (also see [@B60]).

Another notable exception is the *oriens-lacunosum moleculare* (O-LM) inhibitory cell type of the hippocampus, which is not fast-spiking yet has been shown to express functional CP-AMPARs (**Figure [1B](#F1){ref-type="fig"}**). Although the O-LM cell type is typically thought of as the functional hippocampal homologue of the neocortical MC, there are considerable differences when it comes to molecular markers ([@B60]). For example, O-LM cells comprise only about 40% of Sst-expressing INs ([@B56]; [@B17]), and a subset of O-LM cells are in fact positive for Pvalb ([@B17]; [@B14]). In neocortex however, Sst chiefly labels MCs, and Pvalb and Sst labels are essentially mutually exclusive ([@B93]; [@B60]). That hippocampal O-LM cells but not neocortical MCs express CP-AMPARs widely may in other words be yet another difference in terms of molecular properties. The functional implications of this difference between MCs and O-LM cells remain unclear.

Interestingly, high-frequency stimulation was not sufficient to induce LTP at excitatory inputs onto O-LM cells, while a concomitant hyperpolarization of the postsynaptic IN was required for potentiation ([@B57]). Ca^2+^ entry at the synapse was presumably mediated by CP-AMPARs due to the alleviation of the voltage-dependent polyamine block. In contrast, studies in BCs have shown that LTP of excitatory inputs, while also mediated by CP-AMPARs, did not require postsynaptic hyperpolarization ([@B47]; [@B13]). Interestingly, [@B13] demonstrated the involvement of internal Ca^2+^ stores in mediating LTP in the absence of postsynaptic hyperpolarization. Because this mechanism was not identified in O-LM cells, CP-AMPARs may thus play a role in mediating LTP in different cell types via distinct signaling pathways.

The emerging picture is not black-and-white, but quite nuanced. In some brain regions and at certain developmental stages, CP-AMPAR expression goes with cell and synapse type ([@B36]; **Figures [1A](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**), but this may not hold true in other brain regions ([@B89]; **Figure [1B](#F1){ref-type="fig"}**). Yet again, at other time points, factors such as developmental origin may play a relatively more dominant role in determining CP-AMPAR expression patterns ([@B50]).

Functional Implications in Health and Disease
=============================================

The regulation of CP-AMPAR expression implies specific functional relevance, which in turn suggests that CP-AMPAR dysregulation is involved in pathology. Here below, we briefly discuss the functional role of CP-AMPARs in health and disease.

CP-AMPARs have been implicated in controlling synaptic short-term dynamics. [@B45] reported the presence of CP-AMPARs at local but not at long-range inputs to Pvalb-positive INs in L2/3 of the mouse visual cortex. Interestingly, they observed a selective developmental decrease in short-term depression of these local inputs, which correlated with a developmentally increased ratio of CP- to CI-AMPARs. This was supported by rectifying current-voltage relationships and a higher sensitivity to the CP-AMPAR blocker 1-naphthyl acetyl spermine (NASPM) at mature (postnatal day 32--34) short-range excitatory synapses onto Pvalb-positive INs, in comparison to linear current-voltage relationships and less sensitivity to NASPM at both short- and long-range synapses in younger animals (postnatal day 17--19). Furthermore, blocking CP-AMPARs strongly affected the short-term dynamics of mature but not juvenile short-range connections, by rendering them more depressing. During high-frequency stimulation, CP-AMPARs are enhanced by use-dependent relief from polyamine block ([@B68]; [@B69]). Polyamine-dependent facilitation of CP-AMPARs thus counteracts short-term depression at excitatory synapses. This explains how blockade of postsynaptic CP-AMPARs can somewhat counterintuitively increase short-term depression, which is typically attributed to presynaptic mechanisms ([@B1]; [@B7]).

One intriguing aspect of the study by [@B45] -- which echoes the findings of [@B94] in the hippocampus -- is the suggestion that different inputs onto a single Pvalb IN can activate different subtypes of AMPARs. This notion, that plasticity is regulated at the synaptic level, has been termed synapse-type-specific plasticity (STSP) ([@B38]), and may pertain to short as well as long-term plasticity ([@B7]). STSP should thus not be confused with synapse specificity in long-term plasticity, which maximizes information storage by preventing spread of connective strengthening or weakening to neighboring synapses ([@B21]; [@B84]; [@B82]; [@B48]). The synapse-type-specific developmental decrease of short-term depression observed by [@B45] may reflect a key role of CP-AMPARs in neuronal maturation via STSP ([@B38]).

In our study ([@B36]), all experiments were carried out using tissue from mice aged from P14-P21, a relatively narrow age range. In many cell types, the expression of CP-AMPARs has been found to vary with development, as determined by immunolabelling, electrophysiology and/or pharmacology. Unfortunately, no clear-cut universal pattern is apparent: different types of neurons and brain regions have different developmental profiles. For example, several studies have demonstrated a developmental decrease in the expression of CP-AMPARs ([@B35]; [@B79]; [@B58]; [@B86]; [@B45]) while one has shown expression to fluctuate with age ([@B98]). Of greatest relevance to our study, in Pvalb-positive INs of the mouse visual cortex the expression of CP-AMPARs has been shown to be elevated at P31--P34 when compared to that at P17--P19 ([@B45]). Clearly, further studies are required to resolve the developmental regulation of CP-AMPAR expression.

As mentioned earlier, CP-AMPAR developmental regulation suggests a possible contribution to pathology when dysregulated. Indeed, this receptor type has long been suggested to play crucial roles in excitotoxicity and cell death (for reviews, see [@B43]; [@B101]; [@B23]). In particular, an increased expression of CP-AMPARs following neurological insult may enhance glutamate toxicity due to elevated Ca^2+^ influx, a concept known as the GluA2 hypothesis ([@B61]). For example, following seizures of various types, GluA2 expression is decreased ([@B65]; [@B66]; [@B44]). Although lowered GluA2 expression does not necessarily in itself lead to cell death ([@B100]), an increase of CP-AMPAR-dependent Ca^2+^ influx was shown in CA1 hippocampal neurons following hypoxia-induced neonatal seizures ([@B42]). Antagonizing AMPARs with NBQX after *in-vivo* hypoxia prevented both expression of GluA2-lacking AMPARs and the enhanced Ca^2+^ influx ([@B42]). Interestingly, post-hypoxia induction of CP-AMPAR expression correlated with an impairment of LTD, which was restored by *in-vivo* administration of NBQX ([@B42]). Since LTD requires relatively low Ca^2+^ influx, this result is consistent with excess Ca^2+^ influx caused by the increased CP-AMPARs expression following hypoxia. By sequentially blocking CP-AMPARs, NMDARs or L-type Ca^2+^ channels, the authors also demonstrated that the excessive Ca^2+^ influx is primarily due to the expression of CP-AMPARs.

Conclusion and Future Directions
================================

As reviewed above, our work revealed that synapse-specific CP-AMPAR expression at PC-to-BC connections (**Figure [1](#F1){ref-type="fig"}**) helps to further speed up BC inhibition, because of the rapid kinetics of the CP-AMPAR-mediated currents ([@B36]). This implies that CP-AMPARs not only mediate synaptic plasticity ([@B34]), but are also important for proper information transfer across synapses. This conclusion echoes that reached concerning NMDARs, which are well-known for their role in mediating Hebbian plasticity and memory formation ([@B81]; [@B82]; [@B52]; [@B48]), but which also play an important role in neurotransmission and in functional computations of neocortical microcircuits ([@B71]; [@B75]; [@B39]). Interestingly, we found that unlike CP-AMPARs, postsynaptic NMDARs were relatively uniformly and not synapse-specifically expressed in neocortical layer 5 ([@B36]). In contrast, a study by [@B40] revealed a synapse-type-specific expression of postsynaptic NMDARs: while excitatory feed-forward connections onto Pvalb-expressing CA1 INs expressed few NMDARs, feed-back connections onto the same INs expressed high levels of NMDARs, perhaps indicative of a difference between neocortex and hippocampus. On the other hand, *presynaptic* NMDARs (preNMDARs) are expressed in a synapse-specific manner in neocortical circuits, opposite and complementary to that of CP-AMPARs, so that PC-MC but not PC-BC connections possess preNMDARs ([@B11]). This arrangement makes good sense, since preNMDARs help wind up PC-MC excitatory connections during sustained high-frequency firing by boosting the replenishment of the readily releasable pool of vesicles ([@B2]). A functional image of differential inhibitory signaling emerges: while preNMDARs at PC-MC synapses help enable late-onset and sustained inhibition of PCs, CP-AMPARs at PC-BC connections promote brief, rapid-onset inhibition of PCs.

The notion that synaptic properties such as long- and short-term plasticity depend on synapse type, STSP, has gained increasing interest in recent years ([@B7]; [@B38]; [@B55]). This idea, however, has been around since the 1970s, when, for example, it was shown that synapses of the same axon but with differential release properties innervated different muscles ([@B59]). STSP has subsequently been reported in hippocampus ([@B74]; [@B95]; [@B64]; [@B88]; [@B53]), cerebellum ([@B6]), and neocortex ([@B92]; [@B49]; [@B67]). As a general principle, soma-targeting BCs receive short-term depressing excitatory drive, while dendrite-targeting MC-like INs receive facilitating excitatory inputs ([@B7]). This differential arrangement of short-term plasticity separates early- and late-onset inhibition onto soma and dendrites, respectively, of PCs ([@B64]). Future research may reveal how synapse-type-specific expression and functioning of receptors such as CP-AMPARs ([@B36]) and preNMDARs ([@B11]) or down-stream signaling proteins such as RIM1 or JNK2 ([@B2]) control STSP.

The synapse-type-specific expression of CP-AMPARs found in neocortical microcircuits ([@B36]) appears to generalize to other brain regions such as hippocampus ([@B37]; [@B54]), striatum ([@B20]; [@B19]) and cerebellum ([@B84]), but additional work is needed to determine if this holds true at all developmental time points. Although a link between CP-AMPARs and specific forms of long-term plasticity has been quite firmly established ([@B34]; [@B37]; [@B54]; [@B89]), it will be important to understand how synapse-type-specific CP-AMPAR expression impacts circuit remodeling, as well as what the functional consequences are, in health as well as in disease. In particular, the association of synapse-type-specific CP-AMPAR expression with epilepsy and excitotoxicity deserves further exploration. Although the GluA2 hypothesis classically refers to the involvement in disease of principal cells ([@B61]), there is no *a priori* reason to assume that this hypothesis cannot apply to INs. A link between STSP, CP-AMPARs in INs, and pathology thus beckons.
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